Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Profit before tax | 1.02 | 0.10 | 0.17 | 0.72 | 0.95 |
| Net cashflow-operating activity | 7.78 | 0.37 | 1.00 | 0.26 | 0.84 |
| Net cash used in investing activity | -1.53 | -1.81 | -3.11 | -2.45 | -4.75 |
| Netcash used in fin. activity | -6.68 | 1.72 | 1.99 | 2.38 | 3.45 |
| Net inc/dec in cash and equivlnt | -0.42 | 0.28 | -0.12 | 0.18 | -0.46 |
| Cash and equivalnt begin of year | 0.50 | 0.13 | 0.25 | 0.06 | 0.52 |
| Cash and equivalnt end of year | 0.09 | 0.41 | 0.13 | 0.25 | 0.06 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis